Evaluation of the effects of a calcineurin inhibitor in experimental models of Alzheimer’s disease
Sarah Tavares Araújo Santos, Giovanni Freitas Gomes, Nádia Gomes Rocha, Antônio Carlos Pinheiro Oliveira · 2025
Read Evaluation of the effects of a calcineurin inhibitor in experimental models of Alzheimer’s disease by Sarah Tavares Araújo Santos, Giovanni Freitas Gomes, Nádia Gomes Rocha, Antônio Carlos Pinheiro Oliveira (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710743.txt.
Description
Sarah Tavares Araújo Santos and co-authors test a drug in mouse models of Alzheimer's disease in a 2025 study. The drug, FK506, blocks calcineurin, a protein tied to how nerve cells connect and survive. The team asked whether blocking it could protect memory and brain tissue.
They gave the drug to mice harmed by toxins in the hippocampus, to gene-altered mice bred for the disease, and to brain slice cultures. Treated mice kept better memory and social behavior. The drug cut cell death and lowered microglia buildup in the hippocampus. Brain slices also kept more mature nerve cells. The authors see FK506 as a candidate worth more study.
Catalog record
| CREATOR | Sarah Tavares Araújo Santos, Giovanni Freitas Gomes, Nádia Gomes Rocha, Antônio Carlos Pinheiro Oliveira |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |